Not everyone benefits from split dosing
J Inorg Biochem 2009
Our expert team is here to guide you towards achieving smooth, healthy skin from within.
05 Clinical Summary The published protocol, in plain English
dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
When methylation is impaired, it can contribute to major chronic conditions, including cardiovascular diseases, infertility, unexplained miscarriages, problems during pregnancy, mood disorders, free radical damage (premature ageing), diabetes, neural tube defects, neurological conditions, chronic fatigue syndrome
